Freenome, Inc.(FRNM)

Medical - Diagnostics & Research · Brisbane, CA

$16.33-0.50 (-2.99%)

Delayed quote: Oct 6, 2026, 3:40 PM EDT

Compare

Interest Coverage Ratio: N/A

Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.

The interest coverage ratio is N/A as of Tuesday, October 6, 2026.

Interest Expense|Total Debt|Debt/Equity|Operating Margin|All Metrics

FRNM Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

N/A

FRNM Competitors' Interest Coverage Ratio

FRNM

Freenome, Inc.

Current

Market Cap

$133.18M

Interest Coverage Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LFMD

LifeMD, Inc.

vs FRNM

Market Cap

$131.55M

Interest Coverage Ratio

-5.64x

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HCAT

Health Catalyst, Inc.

vs FRNM

Market Cap

$131.16M

Interest Coverage Ratio

-2.20x

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RNA

Atrium Therapeutics, Inc.

vs FRNM

Market Cap

$135.97M

Interest Coverage Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AIRS

AirSculpt Technologies, Inc.

vs FRNM

Market Cap

$130.16M

Interest Coverage Ratio

-0.80x

TTM Avg

1.46x

3Y Avg

2.93x

5Y Avg

2.25x

OGI

Organigram Global Inc.

vs FRNM

Market Cap

$136.58M

Interest Coverage Ratio

N/A

TTM Avg

2.09x

3Y Avg

2.35x

5Y Avg

2.35x

KRMD

KORU Medical Systems, Inc.

vs FRNM

Market Cap

$138.03M

Interest Coverage Ratio

N/A

TTM Avg

346.24x

3Y Avg

936.28x

5Y Avg

577.46x

ACOG

Alpha Cognition Inc

vs FRNM

Market Cap

$138.54M

Interest Coverage Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NRXP

NRx Pharmaceuticals, Inc.

vs FRNM

Market Cap

$127.51M

Interest Coverage Ratio

-24.18x

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PYXS

Pyxis Oncology, Inc.

vs FRNM

Market Cap

$127.44M

Interest Coverage Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Freenome, Inc. (FRNM)	$133.18M	N/A	N/A	N/A	N/A
LifeMD, Inc. (LFMD)vs ›	$131.55M	-5.64x	N/A	N/A	N/A
Health Catalyst, Inc. (HCAT)vs ›	$131.16M	-2.20x	N/A	N/A	N/A
Atrium Therapeutics, Inc. (RNA)vs ›	$135.97M	N/A	N/A	N/A	N/A
AirSculpt Technologies, Inc. (AIRS)vs ›	$130.16M	-0.80x	1.46x	2.93x	2.25x
Organigram Global Inc. (OGI)vs ›	$136.58M	N/A	2.09x	2.35x	2.35x
KORU Medical Systems, Inc. (KRMD)vs ›	$138.03M	N/A	346.24x	936.28x	577.46x
Alpha Cognition Inc (ACOG)vs ›	$138.54M	N/A	N/A	N/A	N/A
NRx Pharmaceuticals, Inc. (NRXP)vs ›	$127.51M	-24.18x	N/A	N/A	N/A
Pyxis Oncology, Inc. (PYXS)vs ›	$127.44M	N/A	N/A	N/A	N/A

Financial Health Indicators

Interest Coverage

N/A

Debt/Equity

N/A

Current Ratio

N/A

Formula: Interest Coverage = EBIT / Interest Expense

Reference ranges:

< 1.5x: EBIT is less than 1.5 times interest expense
1.5x - 3x: EBIT is between 1.5 and 3 times interest expense
3x - 5x: EBIT is between 3 and 5 times interest expense
> 5x: EBIT is more than 5 times interest expense

Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.

Interest Coverage Ratio Formula & Definition

Interest Coverage = EBIT / Interest Expense

The interest coverage ratio measures operating earnings relative to interest expense.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Interest Coverage Ratio: N/A

FRNM Interest Coverage Ratio Metrics

FRNM Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Related Metrics